Cannabinoids play critical roles in human pathophysiology through the cannabinoid (CB) receptors and non-CB receptors on variety of cells, tissues, and organs. Microvasculature with the inside bloodstream containing the plasmatic and cellular components exerts multiple functions in maintaining tissue and organ physiology through microcirculation. This review focusses on the impact of cannabinoids on the microvasculature, including mechanisms mediated by both CB receptor-related pathways and CB receptor-independent pathways.
PisantiS, BifulcoM. Modern history of medical cannabis: From widespread use to prohibitionism and back. Trends Pharmacol Sci. 2017;38:195–8. https://doi.org/10.1016/J.TIPS.2016.12.002.
2.
GaoniY, MechoulamR. Isolation, structure and partial synthesis of an active constituent of hashish. J Am Chem Soc. 196486, 1646–7.
3.
MatsudaLA, LolaitSJ, BrownsteinMJ, YoungAC BTI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 1990;346:561–4. https://doi.org/10.1016/0021-9797(80)90501-9.
4.
MunroS, ThomasKL, Abu-ShaarM. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 1993;365:61–5. https://doi.org/10.1038/365061a0.
5.
di MarzoV. A brief history of cannabinoid and endocannabinoid pharmacology as inspired by the work of British scientists. Trends Pharmacol Sci. 2006;27:134–40. https:org/10.1016/j.tips.2006.01.010.
6.
PacherP, SteffensS, HaskóG, SchindlerTH, KunosG. Cardiovascular effects of marijuana and synthetic cannabinoids: The good, the bad, and the ugly. Nat Rev Cardiol. 2018;15:151–66. https://doi.org/10.1038/nrcardio.2017.130.
7.
AntonovaN, VelchevaI, PaskovaV. Hemorheological and microvascular disturbances in patients with type 2 diabetes mellitus. Clin Hemorheol Microcirc. 2022;81:325–41. https://doi.org/10.3233/CH-221393.
8.
MalinowskaB, GodlewskiG, BucherB, SchlickerE. Cannabinoid CB1 receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat. Naunyn Schmiedebergs Arch Pharmacol. 1997;356:197–202.https://doi.org/10.1007/PL00005041.
9.
MensahE, TabrizchiR, DaneshtalabN. Pharmacognosy and effects of cannabinoids in the vascular system. ACS Pharmacol Transl Sci. 202251034–49. https://doi.org/10.1021/acsptsci.2c00141.
10.
BatkaiS, PacherP, Osei-HyiamanD, RadaevaS, LiuJ, Harvey-WhiteJ, et alEndocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension. Circulation. 2002110https://doi.org/10.1161/01.CIR.0000143230.23252.D2.
11.
Leite-AvalcaMCG, ZampronioAR, LehmannC. Cannabinoid receptor 1 and 2 signalling pathways involved in sepsis. Shock2021.
12.
PatelKD, DavisonJS, PittmanQJ, SharkeyKA. Cannabinoid CB(2) receptors in health and disease. Curr Med Chem. 201017, 1393–410.
13.
Theetha KariyannaP, SmithLR, PatwaK, SalifuMO, McFarlaneIM. Marijuana and microcirculation: A review. Am J Med Case Rep. 2020;8:284–8. org/10.12691/ajmcr-8-9-8.
14.
ZhouJ, KamaliK, LafreniereJD, LehmannC. Real-time imaging of immune modulation by cannabinoids using intravital fluorescence microscopy. Cannabis Cannabinoid Res. 2021;6. https://doi.org/10.1089/can.2020.0179.
15.
BergerG, AroraN, BurkovskiyI, XiaY, ChinnaduraiA, LehmannC. Experimental cannabinoid 2 receptor activation by phyto-derived and synthetic cannabinoid ligands in LPS-Induced interstitial cystitis in mice. Molecules201924:4239.
SzczesniakA, PorterR, ToguriJ, Borowska-FieldingJ, SiwakotiA, LehmannC,
et alCannabinoid 2 receptor is a novel anti-inflammatory target in experimental proliferative vitreoretinopathy. Neuropharmacol2017;113:627–38.
19.
ToguriJT, LehmannC, LaprairieRB, SzczesniakAM, ZhouJ, Denovan-WrightEM,
et alAnti-inflammatory effects of cannabinoid CB2 receptor activation in endotoxin-induced uveitis. Br J Pharmacol. 2014;171:1448–61. https://doi.org/10.1111/bph.12545.
20.
LehmannC, KianianM, ZhouJ, KüsterI, KuschnereitR, WhynotS,
et al. Cannabinoid receptor 2 activation reduces intestinal leukocyte recruitment and systemic inflammatory mediator release in acute experimental sepsis. Crit Care. 2012;16:R47. https://doi.org/10.1186/cc11248.
21.
ZhouJ,
YangH,
LehmannC. Inhibition of GPR 55 improves dysregulated immune response in experimental sepsis. Clin Hemorheol Microcirc. 2018;70(4):553–561. https://doi.org/10.3233/CH-18932.
MovahedP, JönssonBAG, BirnirB, WingstrandJA, JørgensenTD, ErmundA,
et al. Endogenous unsaturated C18 N-acylethanolamines are vanilloid receptor (TRPV1) agonists. Journal of Biological Chemistry. 2005;280:38496–504. https://doi.org/10.1074/jbc.M507429200.
25.
AlsuleimaniYM, HileyCR. Mechanisms of vasorelaxation induced by oleoylethanolamide in the rat small mesenteric artery. Eur J Pharmacol. 2013;702:1–11. https://doi.org/10.1016/J.EJPHAR.2013.01.006.
26.
WhiteR, Vanessa HoWSV, BottrillFE, FordWR, HileyCR. Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries. Br J Pharmacol. 2001;134:921–9. https://doi.org/10.1038/SJ.BJP.0704333.
27.
RajeshM, MukhopadhyayP, HaskóG, LiaudetL, MacKieK, PacherP. Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells. Br J Pharmacol. 2010;160:688–700. https://doi.org/10.1111/J.1476-5381.2010.00712.X.
28.
RandallMD, KendallDA. Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation. Eur J Pharmacol. 1997;335:205–9. https://doi.org/10.1016/S0014-2999(97)01237-5.
29.
AsmarS, NelsonA, AnandT, HammadA, ObaidO, DitilloM,
et al. Marijuana and thromboembolic events in geriatric trauma patients: The cannabinoids clots correlation! Am J Surg2022;223:798–803. https://doi.org/10.1016/J.AMJSURG.2021.07.036.
30.
KhayatW, LehmannC. The endocannabinoid system: A potential therapeutic target for coagulopathies. Metabolites. 2022;12. https://doi.org/10.3390/METABO12060541.
31.
JamesTR, RichardsAA, LoweDA, ReidWA, WatsonCT, PeppleDJ. The in vitro effect of delta-9-tetrahydrocannabinol and cannabidiol on whole blood viscosity, elasticity and membrane integrity. J Cannabis Res. 2022;4. https://doi.org/10.1186/S42238-022-00126-Z.
32.
Stanke-LabesqueF, MallaretM, LefebvreB, HardyG, CaronF, BessardG. 2-Arachidonoyl glycerol induces contraction of isolated rat aorta: Role of cyclooxygenase-derived products. Cardiovasc Res. 2004;63:155–60. https://doi.org/10.1016/J.CARDIORES.2004.03.024/2/63-1-155-FIG3.GIF.
33.
StanleyCP, HindWH, TufarelliC, O’SullivanSE. Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation. Cardiovasc Res.2015;107:568–78. https://doi.org/10.1093/CVR/CVV179.
34.
Baranowska-KuczkoM, KozłowskaH, KlozaM, SadowskaO, KozłowskiM, KusaczukM,
et al. Vasodilatory effects of cannabidiol in human pulmonary and rat small mesenteric arteries: Modification by hypertension and the potential pharmacological opportunities. J Hypertens. 2020;38:896–911. https://doi.org/10.1097/HJH.0000000000002333.
